New Benchmark Study Reveals Benefits of Active Surveillance for Non-Aggressive Prostate Tumors
A new study has revealed that, patients diagnosed with low and moderate-risk prostate tumors, there may be benefits of active surveillance and how it may be a viable option for treatment.